Obstetric Tamponade System
Clinical Innovations

Clinical Innovation is a U.S. medical device company specialising in women’s health. This device revolutionises the treatment of postpartum haemorrhage, the leading cause of maternal mortality.

Postpartum Haemorrhage (PPH) can occur when the mother loses a significant amount of blood after childbirth.

PPH is consistently one of the top three causes of maternal mortality and is often the leading cause of maternal death; even in developed countries. Studies suggest that 73-93% of bleeding deaths are preventable.

Early and proper intervention is vital. A rapid-response system is critical. Ebb provides a complete tamponade solution to the emergency of postpartum haemorrhage.


One balloon is inflated in the womb and another just outside to stop postpartum bleeding. The malleable balloons design allows it to conform to the patient’s anatomy. The unique second balloon anchors the system, reducing the risk of device expulsion.

Central catheter lumens allow for the controlled aspiration and flushing of the site and help confirm that the treatment has been successful. The unprecedented level of control this design delivers has lead to a dramatic improvement in patient outcomes in the field.

Treatment of Postpartum Haemorrhage

MRI of the EBB Complete Tamponade System in the uterus and vagina.


"We have presented the successful conservative management of a case of concomitant severe vaginal lacerations and uterine atony using a complete balloon tamponade system."

Atilgan R, et al. BMJ Case Rep 2014.

Synecco Logo (White).png

Design Centre

Block 12

Galway Technology Park



H91 E4YD

+353 91 577 978

Manufacturing Site

Scariff Road


Co. Clare

V94 FA03

+353 61 921 355

Design, Development & Contract Manufacturing

Solutions for the Life Science Sectors


Copyright 2020 Synecco Ltd | All Rights Reserved